Since 2016, Logiprem-F has developed Logipren, a SaaS platform that supports medication prescription processes for neonatal and paediatric intensive care units. A market leader in France in this segment, the company now supports more than 90 hospitals and has a team of around 40 employees, helping secure the entire prescription and administration pathway for newborns and young patients.

This transaction forms part of Evolucare and the GPI group’s strategy to strengthen their “critical care” division and consolidate their position as a leading European provider of critical care software, particularly in France and across major European markets.

Reed Smith acted as legal counsel to the shareholders of Logiprem-F on the corporate aspects of the transaction. The team included Marc Fredj (partner), Antea Bonito (associate), and Camille Diz (legal counsel).

The buyer, Evolucare Technologies, was advised by GWL Avocats, led by Siham Belarbi (partner).